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Abstract:  Five new cembrane-type diterpenoids, lobocrassins A–E (1–5), were isolated 
from the soft coral Lobophytum crassum. The structures of cembranes 1–5 were established 
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by spectroscopic and chemical methods and by comparison of the spectral data with those 
of known cembrane analogues. Lobocrassin A (1) is the first cembranoid possessing an  
α-chloromethyl-α-hydroxy-γ-lactone functionality and is the first chlorinated cembranoid 
from soft corals belonging to the genus Lobophytum. Lobocrassins B (2) and C (3) were 
found  to  be  the  stereoisomers  of  the  known  cembranes,  14-deoxycrassin  (6)  and 
pseudoplexaurol (7), respectively. Lobocrassin B (2) exhibited modest cytotoxicity toward 
K562,  CCRF-CEM,  Molt4,  and  HepG2  tumor  cells  and  displayed  significant  
inhibitory  effects  on  the  generation  of  superoxide  anion  and  the  release  of  elastase  by 
human neutrophils.  
Keywords:  lobocrassin;  cembrane;  Lobophytum  crassum;  cytotoxicity;  superoxide  
anion; elastase 
 
1. Introduction  
Among the diterpenoids isolated from octocorals, the cembrane-type metabolites are the largest 
group of compounds [1], and the soft coral Lobophytum crassum (family Alcyoniidae) has been proven 
to  be  a  rich  source  of  cembrane-type  compounds  [2–13].  In  our  continuing  research  on  novel 
substances from the octocorals distributed in the waters of Taiwan at the intersection of the Kuroshio 
current and the South China Sea surface current, the soft coral L. crassum was studied to determine the 
properties  of  its  organic  extract,  which  displayed  cytotoxicity  toward  MCF-7  (human  breast 
adenocarcinoma) and HeLa (human cervical carcinoma) cells (IC50 = 10.2 and 8.8 µg/mL, respectively). 
Five new cembrane derivatives, lobocrassins A–E (1–5) (Figure 1), were isolated. In this paper, we 
report the isolation, structure determination, and bioactivity of cembranes 1–5. 
Figure  1.  The  structures  of  lobocrassins  A–E  (1–5),  14-deoxycrassin  (6),  and 
pseudoplexaurol (7). 
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Figure 1. Cont. 
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2. Results and Discussion  
Lobocrassin A (1) was isolated as a colorless oil, and the molecular formula for this compound was 
determined  to  be  C20H29ClO4  (six  units  of  unsaturation)  using  HRESIMS  (C20H29
35ClO4  +  H,  
m/z 369.1830, calculated 369.1833). Comparison of the 
13C NMR and DEPT data with the molecular 
formula indicated that there must be an exchangeable proton, which required the presence of a hydroxy 
group. This deduction was supported by a broad absorption in the IR spectrum at 3385 cm
–1. The IR 
spectrum also showed a strong band at 1778 cm
–1, consistent with the presence of a γ-lactone moiety. 
The 
13C NMR data for 1 confirmed the presence of twenty carbon signals (Table 1), characterized by 
DEPT  as  three  methyls,  seven  sp
3  methylenes,  two  sp
2  methines,  three  sp
3  methines,  three  sp
2 
quaternary carbons, and two sp
3 quaternary carbons. Based on the 
1H and 
13C NMR spectra (Table 1), 
1 was determined to possess a γ-lactone (δC 173.4, C-17) and two trisubstituted olefins (δH 5.23, 1H, 
dd, J = 6.4, 6.4 Hz, H-11; 5.07, 1H, dd, J = 6.4, 6.4 Hz, H-7; δC 135.2, C-8; 130.2, CH-11; 130.1,  
C-12; 122.5, CH-7). The presence of a trisubstituted epoxide containing a methyl substituent  was 
established from the signals of an oxygenated quaternary carbon (δC 64.0, C-4) and an oxymethine  
(δH 2.86, 1H, dd, J = 8.4, 4.4 Hz; δC 60.3, CH-3), and it was confirmed by the proton signal of a 
methyl singlet at δH 1.34 (3H, s, H3-18). Thus, from the reported data, the proposed skeleton of 1 was 
suggested to be a cembrane-type diterpenoid with three rings. 
From the 
1H–
1H COSY spectrum of 1 (Table 1), it was possible to differentiate among the separate 
spin systems of H-3/H2-2/H-1/H-14/H2-13, H2-5/H2-6/H-7, and H2-9/H2-10/H-11. These data, together 
with the key HMBC correlations between protons and quaternary carbons of 1, such as H2-2, H-5a,  
H-6a/C-4; H2-6, H2-9, H2-10/C-8; H2-10, H2-13, H-14/C-12; H-2a, H2-16, OH-15/C-15; and H2-16, 
OH-15/C-17, permitted the elucidation of the carbon skeleton. The vinyl methyls attached at C-8 and 
C-12 were confirmed by the HMBC correlations between H-7, H2-9/C-19; H3-19/C-7, C-8, C-9; and 
H-11/C-20;  H3-20/C-11,  C-12,  C-13  and  were  further  supported  by  the  allylic  couplings  between  
H-7/H3-19  and  H-11/H3-20.  The  C-3/4  epoxide  group  was  confirmed  by  the  HMBC  correlations 
between H2-2, H2-5/C-3; H2-2, H-5a, H-6a/C-4; and H3-18/C-3, C-4, C-5. The presence of a hydroxy 
group at C-15 was deduced from the HMBC correlations between the hydroxy proton (δH 4.03, br s, 
OH-15) with C-1, C-15, C-16, and C-17. Mar. Drugs 2011, 9 
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Table 1. 
1H and 
13C NMR, 
1H–
1H COSY, and HMBC correlations for cembranoid 1. 
C/H 
1H 
a 
13C 
b 
1H–
1H COSY  HMBC (H→C) 
1  2.76 ddd (10.0, 5.2, 4.0) 
c  44.4  (CH) 
d  H2-2, H-14  C-2, C-13, C-14, C-16 
2a 
b 
2.14 ddd (15.6, 5.2, 4.4) 
1.68 ddd (15.6, 8.4, 4.0) 
23.5  (CH2)  H-1, H-2b, H-3 
H-1, H-2a, H-3 
C-1, C-3, C-4, C-14, C-15 
C-1, C-3, C-4, C-14 
3  2.86 dd (8.4, 4.4)  60.3  (CH)  H2-2  C-2 
4    64.0  (C)     
5a 
b 
2.07 m  
1.29 m 
38.0  (CH2)  H-5b, H2-6 
H-5a, H2-6 
C-3, C-4, C-7 
C-3 
6a 
b 
2.24 m 
2.09 m 
23.4  (CH2)  H2-5, H-6b, H-7 
H2-5, H-6a, H-7 
C-4, C-7, C-8 
C-7, C-8 
7  5.07 dd (6.4, 6.4)  122.5  (CH)  H2-6, H3-19  C-6, C-9, C-19 
8    135.2  (C)     
9a 
b 
2.26 m 
2.04 m 
38.8  (CH2)  H-9b, H2-10 
H-9a, H2-10 
C-7, C-8, C-10, C-11, C-19 
C-7, C-8, C-10, C-11, C-19 
10a 
b 
2.32 m 
2.21 m 
24.8  (CH2)  H2-9, H-10b, H-11 
H2-9, H-10a, H-11 
C-8, C-9, C-11, C-12 
C-8, C-9, C-11, C-12 
11  5.23 dd (6.4, 6.4)  130.2  (CH)  H2-10, H3-20  C-9, C-10, C-20 
12    130.1  (C)     
13a 
b 
2.67 br d (14.4) 
2.52 dd (14.4, 7.2) 
43.0  (CH2)  H-13b, H-14 
H-13a, H-14 
C-1, C-11, C-12, C-14 
C-1, C-11, C-12, C-14 
14  4.66 ddd (10.0, 7.2, 2.8)  80.0  (CH)  H-1, H2-13  C-12 
15    77.2  (C)     
16a 
b 
3.79 d (11.6) 
3.53 d (11.6) 
44.5  (CH2)  H-16b 
H-16a 
C-1, C-15, C-17 
C-1, C-15, C-17 
17    173.4  (C)     
18  1.34 s  17.0  (CH3)    C-3, C-4, C-5 
19  1.60 s  15.7  (CH3)  H-7  C-7, C-8, C-9 
20  1.74 s  17.4  (CH3)  H-11  C-11, C-12, C-13 
OH-15  4.03 br s        C-1, C-15, C-16, C-17 
a Spectra were measured at 400 MHz in CDCl3 at 25 °C; 
b Spectra were measured at 100 MHz in CDCl3 at  
25 °C; 
c J values (in hertz) are in parentheses; 
d Multiplicity was deduced by DEPT and HMQC experiments 
and indicated by the usual symbols. 
The intensity of hydrogenated molecular (M + 2 + H)
+ isotope peaks observed in the ESIMS and 
HRESIMS spectra [(M + H)
+:(M + 2 + H)
+ = 3:1] provided strong evidence for the presence of a 
chlorine atom in 1. The methylene unit at δC 44.5 (CH2-16) was more shielded than expected for an 
oxygenated C-atom and was correlated to the methylene protons at δH 3.79 (H-16a) and 3.53 (H-16b) 
in the HMQC spectrum. These two protons showed a typical geminal coupling pattern with each other 
(J = 11.6 Hz), and these two proton signals were 
2J-correlated with C-15 and 
3J-correlated with C-1 
and C-17 in the HMBC spectrum, demonstrating the attachment of a chlorine atom at C-16. Based on 
the above findings, the molecular framework of 1 was established unambiguously. 
The  relative  configuration  of  1  was  elucidated  from  the  interactions  observed  in  a  NOESY 
experiment. Most naturally occurring cembrane-type natural products from soft corals belonging to the 
order Alcyonacea have the H-1 in the β-orientation [14]. In the NOESY experiment for 1 (Figure 2), Mar. Drugs 2011, 9 
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correlations observed between H-7 and H2-9 and H-11 and H2-13, as well as the lack of correlation 
between  H-7/H3-19  and  H-11/H3-20,  reflected  the  E  geometry  of  the  double  bonds  at  C-7/8  and  
C-11/12. Additionally, H-1 correlated with H-13b (δH 2.52), whereas H-14 showed responses to H-13a 
(δH 2.67), and the absence of correlation between H-1 and H-14 suggested a trans-fused γ-lactone in 1. 
Moreover,  it  was  found  that  H-14  showed  interactions  with  H-3  and  H3-20.  Thus,  assuming  the  
α-orientation of H-14, H-3 should be positioned on the α face. In addition, H3-18 was found to interact 
with H-2a (δH 2.14), but not with H-3, revealing the trans geometry of the trisubstituted epoxide. H-1 
correlated with H-16a/b, indicating that the C-16 methylene was situated on the β face in 1. Based on 
the above findings, the structure of 1 was elucidated and the chiral centers for 1 were assigned as 1S*, 
3S *, 4S*, 14S*, and 15S*.  
In  previous  studies,  chlorinated  cembranoids  have  rarely  been  found  [15–17].  To  the  best  
of  our  knowledge,  lobocrassin  A  (1)  is  therefore  the  first  cembranoid  possessing  an  
α-chloromethyl-α-hydroxy-γ-lactone  functionality,  and  this  compound  is  also  the  first  chlorinated 
cembranoid from soft corals belonging to the genus Lobophytum. 
Figure 2. Computer-generated model for 1 using MM2 force field calculations and key 
NOESY correlations. 
 
Cembranoid  2  (lobocrassin  B),  obtained  as  a  colorless  oil,  showed  an  (M  +  Na)
+  signal  at  
m/z 341.2091 in the HRESIMS, suggesting the molecular formula C20H30O3 (calcd C20H30O3 + Na, 
341.2093), with six units of unsaturation. The IR absorptions of 2 at 3453 and 1721 cm
–1 indicated the 
presence of hydroxy and δ-lactone functionalities. Through detailed analysis, cembranoid 2 had the 
same molecular formula as that of a well-known cembrane metabolite, 14-deoxycrassin (6), which was 
first isolated from the Caribbean gorgonian coral Pseudoplexaura porosa [18]. It was subsequently 
found that the spectral data of 2 were similar to those of 6. However, by comparison of the optical 
rotation values and 
13C NMR chemical shifts of the C-1 methine of 2 ([α]
25
D −40 (c 0.07, CHCl3);  
δC 35.5, CH-1) with that of 6 ([α]
26
D +29.6 (c 0.24, CHCl3); δC 33.23, CH-1), it was shown that the C-1 
methine  proton  in  2  was  β-oriented.  Therefore,  this  compound  should  possess  structure  2.  The 
structure of 2 was further confirmed by 2D NMR experiments (Table 2), and the chiral centers for this 
compound were assigned as 1R*, 3S*, and 4R*. Mar. Drugs 2011, 9 
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Table 2. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for cembranoid 2. 
C/H 
1 H 
a 
13C 
b 
1H–
1H COSY  HMBC (H→C) 
1  2.70 m  35.5  (CH) 
d  H2-2, H-14  C-15, C-16, C-17 
2  1.98 m  25.2  (CH2)  H-1, H-3  C-1, C-3, C-4, C-14, C-15 
3  4.29 dd (8.0, 5.5) 
c  79.9  (CH)  H2-2  C-1, C-4, C-5, C-18 
4    74.6  (C)     
5a 
b 
1.87 m 
1.68 ddd (14.5, 9.5, 4.5) 
37.4  (CH2)  H-5b, H2-6 
H-5a, H2-6 
C-3, C-4, C-6, C-7, C-18 
C-3, C-4, C-6, C-7, C-18 
6a  2.22 m  22.4  (CH2)  H2-5, H-6b, H-7  C-4, C-5, C-7, C-8 
b  2.16 m      H2-5, H-6a, H-7  C-4, C-5, C-7, C-8 
7  5.21 dd (7.0, 7.0)  125.6  (CH)  H2-6, H3-19  C-5, C-6, C-9, C-19 
8    135.7  (C)     
9  2.14 m  38.8  (CH2)  H2-10  C-7, C-8, C-10 
10a 
b 
2.22 m  
2.15 m 
24.2  (CH2)  H2-9, H-10b, H-11 
H2-9, H-10a, H-11 
C-8, C-11, C-12 
C-8, C-9, C-11, C-12 
11  5.01 dd (6.5, 6.5)  124.7  (CH)  H2-10  C-10, C-13, C-20 
12    135.3  (C)     
13a 
b 
2.21 m  
2.02 m 
36.1  (CH2)  H-13b, H2-14 
H-13a, H2-14 
C-14 
C-1, C-11, C-12, C-14, C-20 
14a 
b 
1.38 m 
1.90 m 
31.5  (CH2)  H-1, H2-13, H-14b 
H-1, H2-13, H-14a 
C-1, C-2, C-12 
C-12 
15    140.2  (C)     
16    166.5  (C)     
17a 
b 
6.34 s  
5.55 s 
125.7  (CH2)  H-17b 
H-17a 
C-1, C-15, C-16 
C-1, C-16 
18  1.27 s  24.2  (CH3)    C-3, C-4, C-5 
19  1.56 s  15.3  (CH3)  H-7  C-7, C-8, C-9 
20  1.61 s  15.6  (CH3)    C-11, C-12, C-13 
OH-4  1.89 s        C-3, C-4, C-5, C-18 
a Spectra were measured at 500 MHz in CDCl3 at 25 °C; 
b Spectra were measured at 125 MHz in CDCl3 at  
25 °C; 
c J values (in hertz) are in parentheses; 
d Multiplicity was deduced by DEPT and HMQC experiments 
and indicated by the usual symbols. 
The NMR data of 3 (lobocrassin C) were in full agreement with those of a known cembrane analog, 
pseudoplexaurol (7), which was first isolated from the Caribbean gorgonian coral Pseudoplexaura 
porosa [18] and subsequently synthesized [19]. However, the optical rotation value of 3 ([α]
24
D +17 (c 0.37, 
CHCl3)) was substantially different from that of 7 ([α]
26
D −21.5 (c 3.4, CHCl3)), suggesting that 3 was 
an enantiomer of 7. In the NOESY spectrum of 3, H-3 showed a correlation with H-1, but not with  
H3-18, indicating that H-1 and H-3 were β-oriented and H3-18 was α-oriented in 3. Thus, the chiral 
centers for 3 should be assigned as 1R*, 3R*, and 4R*. 
Lobocrassin  D  (4)  had  a  molecular  formula  of  C22H34O3  as  determined  by  HRESIMS  at  
m/z 347.2580 (calcd for C22H34O3 + H, 347.2588). Detailed analysis of the spectral data showed that 
the data for 4 were similar to those of lobocrassin C (3). However, the signals corresponding to the  
16-hydroxy group in 3 (δH 4.06, 2H, br s; δC 64.6, CH2-16) was replaced by those of an acetoxy group 
(δH 4.52, 1H, d, J = 20.8 Hz; 4.49, 1H, d, J = 20.8 Hz; δC 65.5, CH2-16; δH 2.08, 3H, s, acetate methyl; Mar. Drugs 2011, 9 
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δC 170.6, acetate carbonyl; 21.0, acetate methyl) in 4. Furthermore, acetylation of 3 gave a less polar 
product, which was found to be identical with natural product 4 and confirmed as cembranoid 4. 
Lobocrassin  E  (5)  has  the  same  molecular  formula  as  that  of  3,  C20H30O2,  as  determined  by 
HRESIMS at m/z 327.2298 (calcd for C20H30O2 + Na, 327.2300) and with six units of unsaturation. 
These results indicated that compounds 3 and 5 were isomers. By comparison of the NMR data of 5 
(Table 3) with those of 3, the hydroxymethyl group in 3 (δH 4.06, 2H, br s; δC 64.6, CH2-16) was 
replaced  by  a  vinyl  methyl  (δH  1.71,  3H,  s;  δC  18.8,  CH3-16)  in  5,  and  the  C-13  methylene  in  
3 (δH 2.11, 1H, m; 1.93, 1H, m; δC 35.0, CH2-13) was replaced by an oxymethine in 5 (δH 4.19, 1H, m; 
δC 76.6, CH-13). As mentioned for 1, H-1 was suggested to be on the β face in 5. In the NOESY 
experiment  of  5,  H-3  exhibited  correlations  with  H-1  and  H-13  and  no  correlation  was  observed 
between H-3 and H3-18. From consideration of molecular models, H-3 was found to be reasonably 
close to H-1 and H-13 when H-3 was β-oriented and H-13 was placed on the α face. Based on the 
above findings, the relative configurations of the chiral centers for 5 were assigned as 1R*, 3R*, 4R*, 
and 13S*. In a previous study, a ketone analogue of cembranoid 5, (1S*,3S*,4S*,7E,11Z)-3,4-epoxy-
13-oxo-7,11,15-cembratriene,  was  isolated  from  an  unidentified  South  Pacific  soft  coral  [20]. 
Lobocrassin E (5) was subsequently proven to be an epimer of the alcohol derivative of (1S*,3S*,4S*, 
7E,11Z)-3,4-epoxy-13-oxo-7,11,15-cembratriene. 
Table 3. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for cembranoid 5. 
C/H 
1 H 
a 
13C 
b 
1H–
1H COSY  HMBC (H→C) 
1  2.05 m  39.3  (CH) 
d  H2-2, H-14  n.o. 
e 
2a 
b 
1.89 ddd (14.5, 5.0, 4.0) 
c 
1.46 ddd (14.5, 10.5, 3.5) 
33.9  (CH2)  H-1, H-2b, H-3 
H-1, H-2a, H-3 
C-1, C-3, C-4, C-14, C-15 
C-1, C-3, C-4, C-14, C-15 
3  2.85 dd (10.5, 4.0)  62.8  (CH)  H2-2  C-2, C-5 
4    61.0  (C)     
5a 
b 
2.03 m 
1.35 m 
38.0  (CH2)  H-5b, H2-6 
H-5a, H2-6 
C-3, C-4, C-6, C-7 
C-6, C-7 
6a 
b 
1.99 m 
2.17 m 
23.1  (CH2)  H2-5, H-6b, H-7 
H2-5, H-6a, H-7 
C-4, C-7 
C-7 
7  5.11 dd (6.5, 6.5)  125.2  (CH)  H2-6, H3-19  C-6, C-9, C-19 
8    134.6  (C)     
9  2.25 m  39.6  (CH2)  H2-10  C-8, C-11 
10a 
b 
2.23 m  
2.21 m 
24.4  (CH2)  H2-9, H-10b, H-11 
H2-9, H-10a, H-11 
C-9, C-12 
C-9, C-12 
11  5.39 dd (7.0, 7.0)  128.7  (CH)  H2-10, H3-20  C-10, C-13, C-20 
12    136.1  (C)     
13  4.19 m   76.6  (CH)  H2-14  n.o. 
14  1.72 m  40.3  (CH2)  H-1, H-13  C-1, C-2, C-12, C-13, C-15 
15    150.1  (C)     
16  1.71 s  18.8  (CH3)  H2-17  C-1, C-15, C-17 
17a 
b 
4.68 s  
4.65 s 
109.8  (CH2)  H3-16, H-17b 
H3-16, H-17a 
C-1, C-16 
C-1, C-16 Mar. Drugs 2011, 9 
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Table 3. Cont. 
18  1.20 s  17.6  (CH3)    C-3, C-4, C-5 
19  1.62 s  15.3  (CH3)  H-7  C-7, C-8, C-9 
20  1.62 s  10.5  (CH3)  H-11  C-11, C-12, C-13 
a Spectra were measured at 500 MHz in CDCl3 at 25 °C; 
b Spectra were measured at 125 MHz in CDCl3 at 
25 °C; 
c J values (in hertz) are in parentheses; 
d Multiplicity was deduced by DEPT and HMQC experiments 
and indicated by the usual symbols; 
e n.o. = not observed. 
The  cytotoxicity  of  cembanes  1–4  toward  K562  (human  erythromyeloblastoid  leukemia),  
CCRF-CEM  (human  T-cell  acute  lymphoblastic  leukemia),  Molt4  (human  acute  lymphoblastic 
leukemia), HepG2 (human hepatocellular liver carcinoma), and Huh 7 (human hepatocellular liver 
carcinoma)  tumor  cells  were  studied,  and  the  results  are  shown  in  Table  4.  The  data  show  that 
lobocrassin B (2) exhibited modest cytotoxicity against K562, CCRF-CEM, Molt4, and HepG2 cells.  
Table 4. Cytotoxicity of cembranes 1–4. 
  Cell lines IC50 (µg/mL) 
Compounds  K562  CCRF-CEM  Molt4  HepG2  Huh 7 
1  15.39  5.33  11.86  32.16  26.13 
2  2.97  0.48  0.34  3.44  8.17 
3  >40  11.55  9.51  >40  39.77 
4  24.00  10.53  10.99  34.91  >40 
Doxorubicin 
a  0.24  0.05  0.07  0.71  0.46 
a Doxorubicin was used as a reference compound. The results are expressed as mean ± S.D.  
In addition, the in vitro anti-inflammatory effects of cembranes 1–5 were tested. Lobocrassin B (2) 
displayed  significant  inhibitory  effects  on  the  generation  of  superoxide  anion  and  the  release  of 
elastase by human neutrophils (Table 5). 
Table 5. Inhibitory effects of cembranes 1–5 on the generation of superoxide anion and the 
release of elastase by human neutrophils in response to formyl-Met-Leu-Phe/cytochalasin 
B (FMLP/CB). 
  Superoxide anion    Elastase release 
Compounds  IC50 (µg/mL) or (Inh %) 
a    IC50 (µg/mL) or (Inh %) 
a 
1  (2.8 ± 1.9)    (0.9 ± 2.5) 
2  4.8 ± 0.7    4.9 ± 0.4 
3  (1.4 ± 2.4)    (9.6 ± 9.4) 
4  (−1.9 ± 7.3)    (11.0 ± 3.9) 
5  (−1.2 ± 1.5)    (−4.4 ± 9.5) 
DPI 
b  0.8 ± 0.2     
Elastatinal 
b      30.8 ± 5.7 
a  Percentage  of  inhibition  (Inh  %)  at  a  concentration  10  µg/mL; 
b  DPI  (diphenylene  indoniumn)  and 
elastatinal were used as reference compounds. Results are expressed as mean ± S.E.M., and comparisons 
were made using Student’s t-test. A probability of ≤ 0.05 was considered significant. Mar. Drugs 2011, 9 
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3. Experimental Section 
3.1. General Experimental Procedures 
Optical  rotations  were  measured  on  a  Jasco  P-1010  digital  polarimeter.  Infrared  spectra  were 
recorded on a Varian Diglab FTS 1000 FT-IR spectrometer; peaks are reported in cm
–1. The NMR 
spectra were recorded on Varian Mercury Plus 400 or Varian Inova 500 NMR spectrometers using the 
residual CHCl3 signal (δH 7.26 ppm) as an internal standard for 
1H NMR and CDCl3 (δC 77.1 ppm) for 
13C NMR. Coupling constants (J) are given in Hz. 
1H and 
13C NMR assignments were supported by 
1H–
1H  COSY,  HMQC,  HMBC,  and  NOESY  experiments.  ESIMS  were  recorded  on  a  Thermo 
Finnigan LCQ ion trap or a Bruker APEX II mass spectrometer. HRESIMS data were recorded on 
Thermo  Fischer  Scientific  LTQ  Orbitrap  XL  or  a  Bruker  APEX  II  mass  spectrometers.  Column 
chromatography was performed on silica gel (230–400 mesh, Merck, Darmstadt, Germany). TLC was 
carried out on precoated Kieselgel 60 F254 (0.25 mm, Merck), and spots were visualized by spraying 
with 10% H2SO4 solution followed by heating. HPLC was performed using a system comprised of a 
Hitachi L-7100 pump, a Hitahci L-7455 photodiode array detector, and a Rheodyne injection port.  
A normal phase column (Hibar 250 × 10 mm, Merck, silica gel 60, 5 µm) was used for HPLC. 
3.2. Animal Material 
Specimens of the soft corals L. crassum were collected by hand using scuba equipment off the coast 
of  northeast  Taiwan  at  a  depth  of  10  m  in  August  2007  and  stored  in  a  freezer  until  extraction.  
A voucher specimen (NMMBA-TW-SC-2007-33) was deposited in the National Museum of Marine 
Biology and Aquarium, Taiwan. 
3.3. Extraction and Isolation 
The soft coral L. crassum (wet weight, 1.3 kg) was collected and freeze-dried. The material was 
minced and extracted with ethyl acetate (EtOAc). The EtOAc layer was separated on silica gel and 
eluted using n-hexane/EtOAc (stepwise from 100:1 to 0:100 n-hexane/EtOAc) to obtain 12 fractions. 
Fraction 8, eluted with n-hexane/EtOAc (1:1), was further separated by normal-phase HPLC (NP-HPLC) 
(n-hexane/EtOAc, 7:2) to afford 1 (1.9 mg). Compounds 2 (1.0 mg), 3 (7.3 mg), and 5 (1.2 mg) were 
obtained from fraction 6 by NP-HPLC (n-hexane/EtOAc, 4:1). Fraction 4, eluted with n-hexane/EtOAc 
(15:1–10:1), was separated on a silica gel column and further purified by NP-HPLC (n-hexane/EtOAc, 
22:1) to yield 4 (1.7 mg).  
Lobocrassin  A  (1):  colorless  oil;  [α]
25
D +28  (c  0.63,  CHCl3);  IR  (neat)  νmax  3385,  1778  cm
–1;  
1H (CDCl3, 400 MHz) and 
13C (CDCl3, 100 MHz) NMR data, see Table 1; ESIMS: m/z 369 (M + H)
+, 
 
371 (M + 2 + H)
+; HRESIMS: m/z 369.1830 (calcd for C20H29
35ClO4 + H, 369.1833). 
Lobocrassin  B  (2):  colorless  oil;  [α]
25
D −40  (c  0.07,  CHCl3);  IR  (neat)  νmax  3453,  1721  cm
–1;  
1H (CDCl3, 500 MHz) and 
13C (CDCl3, 125 MHz) NMR data, see Table 2; ESIMS: m/z 341 (M + Na)
+; 
HRESIMS: m/z 341.2091 (calcd for C20H30O3 + Na, 341.2093). Mar. Drugs 2011, 9 
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Lobocrassin C (3): colorless oil; [α]
24
D +17 (c 0.37, CHCl3); IR (neat) νmax 3348 cm
–1; 
1H (CDCl3, 
400 MHz) δH 5.09 (1H, dd, J = 6.4, 6.4 Hz, H-11), 5.08 (1H, d, J = 1.2 Hz, H-17a), 5.07 (1H, dd,  
J = 6.4, 6.4 Hz, H-7), 4.89 (1H, dd, J = 1.2, 0.8 Hz, H-17b), 4.06 (2H, br s, H2-16), 2.81 (1H, dd,  
J = 9.6, 3.6 Hz, H-3), 2.27 (1H, dddd, J = 8.8, 8.8, 6.0, 2.4 Hz, H-1), 2.19 (5H, m, H2-6, H-9a, and  
H2-10),  2.11  (1H,  m,  H-13a),  2.06  (1H,  m,  H-5a),  1.99  (1H,  m,  H-9b),  1.93  (1H,  m,  H-13b),  
1.79 (1H, ddd, J = 14.4, 8.8, 3.6 Hz, H-2a), 1.73 (1H, m, H-14a), 1.64 (1H, m, H-14b), 1.61 (3H, s,  
H3-19), 1.59 (3H, s, H3-20), 1.50 (1H, ddd, J = 14.4, 9.6, 2.4 Hz, H-2b), 1.28 (1H, ddd, J = 11.6,  
10.4,  3.6  Hz,  H-5b),  1.24  (3H,  s,  H3-18); 
13C  (CDCl3,  100  MHz)  δC  152.5  (C-15),  135.2  (C-8),  
133.3 (C-12), 124.4 (CH-11), 123.7 (CH-7), 109.3 (CH2-17), 64.6 (CH2-16), 63.0 (CH-3), 60.7 (C-4), 
39.5 (CH2-9), 38.3 (CH2-5), 37.2 (CH-1), 35.0 (CH2-13), 33.8 (CH2-2), 30.2 (CH2-14), 24.4 (CH2-10), 
23.7 (CH2-6), 17.1 (CH3-20), 16.8 (CH3-18), 15.8 (CH3-19); ESIMS: m/z 327 (M + Na)
+; HRESIMS: 
m/z 327.2299 (calcd for C20H32O2 + Na, 327.2300). 
Lobocrassin D (4): colorless oil; [α]
25
D +71 (c 0.57, CHCl3); IR (neat) νmax 1744 cm
–1; 
1H (CDCl3, 
400  MHz)  δH  5.09  (2H,  dd,  J  =  7.2,  7.2  Hz,  H-7  and  H-11),  5.06  (1H,  d,  J  =  1.6  Hz,  H-17a),  
4.94 (1H, s, H-17b), 4.52 (1H, d, J = 20.8 Hz, H-16a), 4.49 (1H, d, J = 20.8 Hz, H-16b), 2.82 (1H, dd, 
J = 10.0, 3.2 Hz, H-3), 2.29 (1H, m, H-1), 2.20 (1H, m, H-9a), 2.19 (2H, m, H2-10), 2.08 (2H, m, H2-6), 
2.08 (3H, s, acetate methyl), 2.06 (1H, m, H-13a), 1.98 (1H, m, H-5a), 1.96 (1H, m, H-9b), 1.95 (1H, m, 
H-13b), 1.77 (1H, m, H-2a), 1.73 (1H, m, H-14a), 1.61 (3H, s, H3-19), 1.60 (1H, m, H-14b), 1.59 (3H, s, 
H3-20),  1.48  (1H,  ddd,  J  =  14.0,  10.0,  2.4  Hz,  H-2b),  1.29  (1H,  m,  H-5b),  1.25  (3H,  s,  H3-18);  
13C  (CDCl3,  100  MHz)  δC  170.6  (acetate  carbonyl),  135.2  (C-8),  147.3  (C-15),  133.1  (C-12),  
124.3 (CH-11), 123.8 (CH-7), 112.6 (CH2-17), 65.5 (CH2-16), 62.9 (CH-3), 60.7 (C-4), 39.5 (CH2-9), 
38.2 (CH2-5), 37.1 (CH-1), 34.7 (CH2-13), 34.1 (CH2-2), 30.4 (CH2-14), 24.4 (CH2-10), 23.7 (CH2-6), 
21.0  (acetate  methyl),  17.1  (CH3-20),  16.9  (CH3-18),  15.8  (CH3-19);  ESIMS:  m/z  347  (M  +  H)
+; 
HRESIMS: m/z 347.2580 (calcd for C22H34O3 + H, 347.2588). 
Lobocrassin E (5): colorless oil; [α]
25
D +47 (c 0.05, CHCl3); IR (neat) νmax 3420 cm
–1; 
1H (CDCl3, 
500  MHz)  and 
13C  (CDCl3,  125  MHz)  NMR  data,  see  Table  3;  ESIMS:  m/z  327  (M  +  Na)
+; 
HRESIMS: m/z 327.2298 (calcd for C20H32O2 + Na, 327.2300). 
3.4. Acetylation of Lobocrassin C (3) 
Lobocrassin C (3) (3.0 mg) was stirred with 2 mL of acetic anhydride in 2 mL of pyridine for 48 h 
at  room  temperature.  After  evaporation  of  excess  reagent,  the  residue  was  separated  by  column 
chromatography on silica gel to give pure lobocrassin D (4) (n-hexane/EtOAc, 20:1, 3.3 mg, 97%); 
physical  (Rf  and  optical  rotational  values)  and  spectral  (IR, 
1H,  and 
13C  NMR)  data  were  in  full 
agreement with those of natural product 4.  
3.5. Molecular Mechanics Calculations 
Implementation  of  the  MM2  force  field  [21]  in  CHEM3D  PRO  software  from  CambridgeSoft 
Corporation (Cambridge, MA, USA; ver 9.0, 2005) was used to calculate molecular models. Mar. Drugs 2011, 9 
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3.6. Cytotoxicity Testing 
The  cytotoxicity  of  compounds  1–4  was  assayed  with  a  modification  of  the  MTT  
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide]  colorimetric  method.  Cytotoxicity 
assays were carried out according to previously described procedures [22,23]. 
3.7. Superoxide Anion Generation and Elastase Release by Human Neutrophils 
Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. 
Measurements  of  superoxide  anion  generation  and  elastase  release  were  carried  out  according  to 
previously  described  procedures  [24,25].  Briefly,  superoxide  anion  production  was  assayed  by 
monitoring  the  superoxide  dismutase-inhibitable  reduction  of  ferricytochrome  c.  Elastase  release 
experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate. 
4. Conclusions 
In  previous  studies,  a  series  of  cembrane-type  diterpenoids  of  potential  medical  interest  were 
isolated from octocorals belonging to the genus Lobophytum. All corals, including reef-building corals 
and soft corals, are considered threatened species due to global climate change and habitat destruction. 
Therefore, the maintenance and culture of these interesting marine invertebrates as sources of new 
natural  products  of  potential  medical  relevance  is  important.  In  our  continuing  search  for  novel 
substances from marine organisms originally collected from the Indo-Pacific Ocean, the hope is to 
identify  extracts  that  exhibit  interesting  bioactivity.  As  an  example,  the  bioactive  cembranoid 
lobocrassin B (2) was isolated in this study. L. crassum was collected and transplanted back to tanks 
equipped with a flow-through sea water system. Advanced bioactivity testing for this compound will 
be carried out if sufficient material can be collected from culture-type species.  
Acknowledgments 
This research was supported by grants from the National Museum of Marine Biology and Aquarium 
(Grant  No.  100100101  and  No.  100200311):  the  National  Dong  Hwa  University:  the  Division  of 
Marine  Biotechnology,  Asia-Pacific  Ocean  Research  Center,  National  Sun  Yat-sen  University  
(Grant No. 00C-0302-05): the Taiwan Department of Health Clinical Trial and Research Center of 
Excellence  (Grant  No.  DOH  100-TD-B-111-004);  and  the  National  Science  Council  (Grant  No.  
NSC 100-2325-B-291-001, 99-2323-B-291-001, and 98-2320-B-291-001-MY3), Taiwan, awarded to 
Y.-H.K. and P.-J.S. 
References 
1.  Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. 
Nat. Prod. Rep. 2011, 28, 196–268. 
2.  Bowden,  B.F.;  Brittle,  J.A.;  Coll,  J.C.;  Liyanage,  N.;  Mitchell,  S.J.;  Stokie,  G.J.  Studies  of 
Australian soft corals. VI-A new cembranolide diterpene from the soft coral Lobophytum crassum 
(Coelenterata, Anthozoa, Octocorallia, Alcyonacea). Tetrahedron Lett. 1977, 18, 3661–3662. Mar. Drugs 2011, 9 
 
 
1330 
3.  Kinamoni,  Z.;  Groweiss,  A.;  Carmely,  S.;  Kashman,  Y.;  Loya,  Y.  Several  new  cembranoid 
diterpenes from three soft corals of the Red Sea. Tetrahedron 1983, 39, 1643–1648. 
4.  Kashman, Y.; Carmely, S.; Groweiss, A. Further cembranoid derivatives from the Red Sea soft 
corals Alcyonium flaccidum and Lobophytum crassum. J. Org. Chem. 1981, 46, 3592–3596. 
5.  Matthée,  G.F.;  König,  G.M.;  Wright,  A.D.  Three  new  diterpenes  from  the  marine  soft  coral 
Lobophytum crassum. J. Nat. Prod. 1998, 61, 237–240. 
6.  Duh, C.-Y.; Wang, S.-K.; Huang, B.-T.; Dai, C.-F. Cytotoxic cembrenolide diterpenes from the 
Formosan soft coral Lobophytum crassum. J. Nat. Prod. 2000, 63, 884–885. 
7.  Yin,  S.W.;  Shi,  Y.P.;  Li,  X.M.;  Wang,  B.G.  A  novel  hydroperoxyl  substituted  cembranolide 
diterpene from marine soft coral Lobophytum crassum. Chin. Chem. Lett. 2005, 16, 1489–1491. 
8.  Yin, S.-W.; Shi, Y.-P.; Li, X.-M.; Wang, B.-G. A new cembranoid diterpene and other related 
metabolites from the South-China-Sea soft coral Lobophytum crassum. Helv. Chim. Acta 2006, 
89, 567–572. 
9.  Zhang, W.; Krohn, K.; Ding, J.; Miao, Z.-H.; Zhou, X.-H.; Chen, S.-H.; Pescitelli, G.; Salvadori, P.; 
Kurtan, T.; Guo, Y.-W. Structural and stereochemical studies of α-methylene-γ-lactone-bearing 
cembrane diterpenoids from a South China Sea soft coral Lobophytum crassum. J. Nat. Prod. 
2008, 71, 961–966. 
10.  Chao, C.-H.; Wen, Z.-H.; Wu, Y.-C.; Yeh, H.-C.; Sheu, J.-H. Cytotoxic and anti-inflammatory 
cembranoids from the soft coral Lobophytum crassum. J. Nat. Prod. 2008, 71, 1819–1824. 
11.  Lin, S.-T.; Wang, S.-K.; Cheng, S.-Y.; Duh, C.-Y. Lobocrasol, a new diterpenoid from the soft 
coral Lobophytum crassum. Org. Lett. 2009, 11, 3012–3014. 
12.  Wanzola,  M.;  Furuta,  T.;  Kohno,  Y.;  Fukumitsu,  S.;  Yasukochi,  S.;  Watari,  K.;  Tanaka,  C.; 
Higuchi, R.; Miyamoto, T. Four new cembrane diterpenes isolated from an Okinawan soft coral 
Lobophytum crassum with inhibitory effects on nitric oxide production. Chem. Pharm. Bull. 2010, 
58, 1203–1209. 
13.  Vanisree,  M.;  Subbaraju,  G.V.  Alcyonacean  metabolites  VIII—Antibacterial  metabolites  from 
Labophytum crassum of the Indian Ocean. Asian J. Chem. 2002, 14, 957–960. 
14.  Rodríguez, A.D.; Li, Y.; Dhasmana, H.; Barnes, C.L. New marine cembrane diterpenoids isolated 
from the Caribbean gorgonian Eunicea mammosa. J. Nat. Prod. 1993, 56, 1101–1113. 
15.  Wei, X.; Rodríguez, A.D.; Baran, P.; Raptis, R.G.; Sánchez, J.A.; Ortega-Barria, E.; González, J. 
Antiplasmodial cembradiene diterpenoids from a Southwestern Caribbean gorgonian octocoral of 
the genus Eunicea. Tetrahedron 2004, 60, 11813–11819. 
16.  Rudi, A.; Shmul, G.; Benayahu, Y.; Kashman, Y. Sinularectin, a new diterpenoid from the soft 
coral Sinularia erecta. Tetrahedron Lett. 2006, 47, 2937–2939. 
17.  Huang, H.-C.; Chao, C.-H.; Kuo, Y.-H.; Sheu, J.-H. Crassocolides G–M, cembranoids from the 
Formosan soft coral Sarcophyton crassocaule. Chem. Biodivers. 2009, 6, 1232–1242. 
18.  Rodríguez, A.D.; Martínez, N. Marine antitumor agents: 14-deoxycrassin and pseudoplexaurol, 
new cembranoid diterpenes from the Caribbean gorgonian Pseudoplexaura porosa. Experientia 
1993, 49, 179–181. 
19.  Liu,  Z.;  Peng,  L.;  Li,  W.Z.;  Li,  Y.  Asymmetric  total  synthesis  of  pseudoplexaurol  and  
14-deoxycrassin, two antitumor marine cembrane diterpenoids. Synlett 2003, 13, 1977–1980. Mar. Drugs 2011, 9 
 
 
1331 
20.  Ravi, B.N.; Faulkner, D.J. Cembranoid diterpenes from a South Pacific soft coral. J. Org. Chem. 
1978, 43, 2127–2131. 
21.  Allinger, N.L. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 
torsional terms. J. Am. Chem. Soc. 1977, 99, 8127–8134. 
22.  Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; 
Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human 
tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589–601. 
23.  Scudiero,  D.A.;  Shoemaker,  R.H.;  Paull,  K.D.;  Monks,  A.;  Tierney,  S.;  Nofziger,  T.H.;  
Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell 
growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 
48, 4827–4833. 
24.  Hwang,  T.-L.;  Su,  Y.-C.;  Chang,  H.-L.;  Leu,  Y.-L.;  Chung,  P.-J.;  Kuo,  L.-M.;  Chang,  Y.-J. 
Suppression of superoxide anion and elastase release by C18 unsaturated fatty acids in human 
neutrophils. J. Lipid Res. 2009, 50, 1395–1408. 
25.  Hwang, T.-L.; Li, G.-L.; Lan, Y.-H.; Chia, Y.-C.; Hsieh, P.-W.; Wu, Y.-H.; Wu, Y.-C. Potent 
inhibition  of  superoxide  anion  production  in  activated  human  neutrophils  by  isopedicin,  a 
bioactive  component  of  the  Chinese  medicinal  herb  Fissistigma  oldhamii.  Free  Radical  Biol. 
Med. 2009, 46, 520–528. 
Samples Availability: Not available. 
©  2011  by  the  authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 